The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 23, 2025

Filed:

Sep. 03, 2021
Applicant:

Centessa Pharmaceuticals (Uk) Limited, Altrincham, GB;

Inventors:

Bruce Lefker, Swampscott, MA (US);

Karl Gibson, Sandwich, GB;

Matthew Spendiff, Cambridge, GB;

Paul Humphries, Santa Clara, CA (US);

Sarah Bucknell, Cambridge, GB;

Wojciech Zawodny, Cambridge, GB;

Roderick Alan Porter, Hertfordshire, GB;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 487/10 (2006.01); C07D 209/54 (2006.01); C07D 221/20 (2006.01); C07D 403/06 (2006.01); C07D 405/06 (2006.01); C07D 405/14 (2006.01); C07D 413/06 (2006.01);
U.S. Cl.
CPC ...
C07D 487/10 (2013.01); C07D 209/54 (2013.01); C07D 221/20 (2013.01); C07D 403/06 (2013.01); C07D 405/06 (2013.01); C07D 405/14 (2013.01); C07D 413/06 (2013.01);
Abstract

The present disclosure relates to compounds of Formula (I′): and to their prodrugs, pharmaceutically acceptable salts, pharmaceutical compositions, methods of use, and methods for their preparation. The compounds disclosed herein are useful for modulating orexin receptor activity and may be used in the treatment of disorders in which orexin receptor activity is implicated, such as narcolepsy, a hypersomnia disorder, a neurodegenerative disorder, a symptom of a rare genetic disorder, a mental health disorder, a metabolic syndrome, osteoporosis, cardiac failure, coma, or a complication in emergence from anaesthesia.


Find Patent Forward Citations

Loading…